References
- De Luca D, Conti G, Piastra M, Paolillo PM. Flow-cycled versus time-cycled sIPPV in preterm babies with RDS: a breath-to-breath randomised cross-over trial. Arch Dis Child Fetal Neonatal Ed 2009;94:F397–F401.
- Jobe AH. The new BPD. Neoreviews 2006;7:e531–e545.
- Lista G, Castoldi F, Fontana P, Daniele I, Cavigioli F, Rossi S, Mancuso D, Reali R. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomised control trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F85–F89.
- Escobedo MB, Gunkel JH, Kennedy KA, Shattuck KE, Sánchez PJ, Seidner S, Hensley G, Cochran CK, Moya F, Morris B, et al Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr 2004;144:804–808.
- Philip AG. Chronic lung disease of prematurity: a short history. Semin Fetal Neonatal Med 2009;14:333–338.
- Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 2006;91:F132–F135.
- Huszár E, Vass G, Vizi E, Csoma Z, Barát E, Molnár Világos G, Herjavecz I, Horváth I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002;20:1393–1398.
- Canpolat F, Unver M, Eskioğlu F, Kösebalaban S, Durmazlar SP. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease. Int J Dermatol 2006;45:1053–1056.
- Chunn JL, Mohsenin A, Young HW, Lee CG, Elias JA, Kellems RE, Blackburn MR. Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am J Physiol Lung Cell Mol Physiol 2006;290:L579–L587.
- Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, Simeoni U, Speer CP, Valls-I-Soler A, Halliday H; Working Group on Prematurity of the World Association of Perinatal Medicine, European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007;35:175–186.
- Deakins KM. Bronchopulmonary dysplasia. Respir Care 2009;54:1252–1262.
- Oosthuizen HM, Ungerer JPJ, Bissport SH. Kinetic determination of serum adenosine deaminase. Clin Chem 1993;39:2182–2185.
- Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 1992;38:1322–1326.
- Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001;21:105–128.
- Valls MD, Cronstein BN, Montesinos MC. Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol 2009;77:1117–1124.
- Ma B, Blackburn MR, Lee CG, Homer RJ, Liu W, Flavell RA, Boyden L, Lifton RP, Sun CX, Young HW, et al Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 2006;116:1274–1283.
- Volmer JB, Thompson LF, Blackburn MR. Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 2006;176:4449–4458.
- Zhou Y, Schneider DJ, Blackburn MR. Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther 2009;123:105–116.